Direxion Daily Pharmaceutical & Medical Bull 2X Shares PILL 深 滬
等待開盤 06-25 09:30:00 美东时间
16.52
+0.950
+6.10%
華盛通- 最 高17.06
- 今 開15.94
- 成交量 10.92万股
- 最 低 15.94
- 昨 收 15.57
- 總市值 1734.60万
- 52周最高 17.06
- 市盈率 靜 --
- 換手率 10.40%
- 52周最低 5.1315
- 委 比 0.00%
- 總股本 105.00万
- 歷史最高 42.2062
- 量 比 1.62
- 振 幅 7.19%
- 歷史最低 3.527
- 每 手 1
- 風險率 2.62%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-Rio Tinto Says Co, BHP And Caterpillar Launch Battery-Electric Haul Truck Trial In Pilbara
BRIEF-Rio Tinto Says Co, BHP And Caterpillar Launch Battery-Electric Haul Truck Trial In Pilbara June 23 (Reuters) - Rio Tinto Ltd RIO.AX : BHP, RIO TINTO AND CATERPILLAR LAUNCH BATTERY-ELECTRIC HAUL TRUCK TRIAL IN PILBARA Further company coverage: RIO.AX (( Reuters.Briefs@thomsonreuters.com ;))
06-23 12:28
Some US employers to drop coverage of GLP-1 obesity drugs in 2027 as use increases
Some US employers to drop coverage of GLP-1 obesity drugs in 2027 as use increases By Amina Niasse NEW YORK, June 11 (Reuters) - Some employers are planning to drop coverage of GLP-1 drugs for weight loss next year as more people take the medications, counteracting some savings from lower prices for
06-11 18:00
GRAPHIC-Take Five: Definitely, maybe
GRAPHIC-Take Five: Definitely, maybe May 29 (Reuters) - Stop-start efforts by Tehran and Washington to extend their ceasefire and reopen the Strait of Hormuz dominate the market outlook, while U.S. and euro zone data should shed more light on the economic toll of the conflict. Elsewhere, Indian poli
05-29 16:48
UPDATE 3-Novo Nordisk beats quarterly profit forecasts, lifts outlook on Wegovy pill strength
UPDATE 3-Novo Nordisk beats quarterly profit forecasts, lifts outlook on Wegovy pill strength Q1 adjusted operating profit beats forecasts Wegovy pill sales 2.26 bln crowns vs 1.16 bln forecast Novo nudges up full-year guidance, still expects drops Novo trying to reel in U.S. rival Eli Lilly Adds We
05-06 13:36
Novo Nordisk's weight-loss pill boom faces price war test
Novo Nordisk's weight-loss pill boom faces price war test Novo faces battle after US approval of Eli Lilly's obesity pill Danish drugmaker reports Q1 earnings on May 6 First sales data for the Wegovy pill will be closely watched Some investors question if Novo's strategy can counter price war and re
05-05 15:00
Capillary Technologies Closes Acquisition of Mastercard’s Session M Loyalty Business
Capillary Technologies India Ltd. ( ($IN:CAPILLARY) ) has issued an update. Cap...
05-02 03:53
BRIEF-Ford Is Recalling 140,201 U.S. Vehicles Over Damaged Wires - NHTSA
BRIEF-Ford Is Recalling 140,201 U.S. Vehicles Over Damaged Wires - NHTSA April 22 (Reuters) - FORD MOTOR COMPANY IS RECALLING 140,201 U.S. VEHICLES - NHTSA FORD MOTOR COMPANY IS RECALLING SOME U.S. VEHICLES AS DAMAGED WIRES CAN CREATE AN ELECTRICAL SHORT AND CAUSE A FIRE IN THE A-PILLAR AREA, INCREA
04-22 15:15
FOCUS-Americans want weight-loss pills for cost and convenience
FOCUS-Americans want weight-loss pills for cost and convenience Doctors say pills appeal for convenience, lower cost, and needle-free use Lilly's Foundayo and Novo's Wegovy pills to compete for market share Weight-loss drugs remain unaffordable for many, despite lower pill prices By Leah Douglas WAS
04-06 18:00
美股夜盘 | Direxion Daily Pharmaceutical & Medical Bull 2X Shares涨10.54%，最新股价10.17美元
Direxion Daily Pharmaceutical & Medical Bull 2X Shares涨10.54%，报10.17美元
03-30 13:24
BRIEF-J&J Says Icotyde One-Year Results Confirm Lasting Skin Clearance And Favorable Safety Profile In Once‑Daily Pill For Plaque Psoriasis
BRIEF-J&J Says Icotyde One-Year Results Confirm Lasting Skin Clearance And Favorable Safety Profile In Once‑Daily Pill For Plaque Psoriasis March 28 (Reuters) - Johnson & Johnson JNJ.N : J&J: ICOTYDE™ (ICOTROKINRA) ONE-YEAR RESULTS CONFIRM LASTING SKIN CLEARANCE AND FAVORABLE SAFETY PROFILE IN ONCE
03-28 22:03
